Article
Mechanistically Informed Prioritization of RNA–LNP Therapeutics: a Safety-by- Design Framework Integrating Virtual Patients, Synthetic Multi-Omics and Biological Consistency Assessment
2026-08-07
Abstract excerpt
<title>Abstract</title> <p>Background RNA therapeutics are rapidly transforming precision medicine, yet their development requires simultaneous consideration of delivery efficiency, biological efficacy, and immune safety. Existing computational approaches frequently address these objectives separately and rarely connect mechanistic knowledge, artificial intelligence, formulation prioritization, and independent b...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 03c3a0c0-8518-51b5-b7bc-7450f99825c5
- DOI
- 10.21203/rs.3.rs-10513597/v1
